Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic testing in hereditary melanoma.

Hensin Tsao1, Kristin Niendorf

  • 1Wellman Center for Photomedicine, Department of Dermatology, Boston, Massachusetts, USA.

Journal of the American Academy of Dermatology
|November 4, 2004
PubMed
Summary

Commercial genetic testing for hereditary melanoma and other cancer syndromes is advancing. Careful consideration of its clinical use and limitations is crucial for effective molecular medicine practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Applications of Reflectance Confocal Microscopy in Paediatric Dermatology: A Systematic Review.

Experimental dermatology·2026
Same author

Human Genome Promise-Are We There Yet?

JAMA dermatology·2026
Same author

Geographic variation in the impact of novel melanoma therapies on mortality.

Journal of the American Academy of Dermatology·2026
Same author

Differential stability of NRAS and BRAF oncoproteins in melanoma.

The Journal of investigative dermatology·2026
Same author

Germline inactivation of tumor suppressor BAP1 is associated with white spotting.

The Journal of clinical investigation·2026
Same author

KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy.

Cancers·2025

Area of Science:

  • Genetics
  • Oncology
  • Molecular Medicine

Background:

  • Advances in molecular genetics offer new diagnostic tools.
  • Commercial genetic testing for hereditary cancer syndromes is increasingly available.
  • Hereditary melanoma is one such syndrome with available genetic testing.

Purpose of the Study:

  • To highlight the challenges in applying molecular genetics to clinical practice.
  • To address the specific issues and limitations of commercial genetic testing for hereditary melanoma.
  • To guide the translation of genetic testing into routine clinical settings.

Main Methods:

  • Review of current literature on molecular genetics and cancer syndromes.
  • Analysis of the implications of commercial genetic testing in clinical practice.
  • Identification of challenges and limitations in the use of genetic testing.

Main Results:

  • Molecular genetics advances present unique challenges for molecular medicine.
  • Commercial testing for hereditary cancer syndromes, like melanoma, is available.
  • Specific issues regarding the use and limitations of this testing require attention.

Conclusions:

  • Full translation of genetic testing into clinical practice requires careful consideration.
  • Understanding the limitations of commercial genetic tests is essential.
  • Further attention is needed to integrate these tools effectively into patient care.

Related Experiment Videos